FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085472942> ?p ?o ?g. }

• W2085472942 endingPage "S53" @default.
• W2085472942 startingPage "S47" @default.
• W2085472942 abstract "Background Hepatitis C virus (HCV) recurrence in recipients who are viremic at time of liver transplantation (LT) is universal and carries poor prognosis. Pretransplant antiviral therapy to eradicate HCV reduces recurrence, but withdrawal rate is high. We conducted a short-course (4 weeks) of pegylated interferon alpha-2a (Peg-IFN-α2a) plus ribavirin (RBV) to prevent of HCV recurrence. Patients and Methods From October 2009 to December 2011, eighty-eight consecutive HCV patients for living donor LT with potential living donor at Kaohsiung Chang Gung Memorial Hospital were included. Patients were divided into treatment and nontreatment group depending on presence of HCV-RNA. Fixed dosage of Peg-IFN-α2a (135 μg/week) plus RBV (10 mg/kg per day) were given for 4 weeks to treatment group who passed the 4-week waiting time according to clinical safety assessment. Results Forty-eight patients with genotypes 1, 2, and 3 (n=29/18/1) were treated with IFN and RBV combination for 4 (range, 1–9) weeks. Serum HCV RNA became undetectable at transplantation in 26 (54%) patients. No difference between genotypes 1 (n= 14, 48%) and 2/3(n=12, 63%, P=0.25) was observed. Most patients experienced cytopenia during treatment, but no mortality was noted. In the treatment group, 13 patients remained free of HCV infection 6 months after transplant. Virologic response at transplantation (48% vs. 100%, P=0.015) and genotype 2/3 (50% vs. 84%, P=0.01) are strong predictors of lower HCV recurrence rate. Multivariate analysis showed that genotype 2/3 was the only independent predictive factor affecting HCV RNA negativity 6 months after liver transplantation (OR:11.25; P=0.014). Conclusions Short-term pretransplant antiviral therapy is a feasible strategy in preventing HCV recurrence after LDLT especially in genotypes 2 and 3 recipients." @default.
• W2085472942 created "2016-06-24" @default.
• W2085472942 creator A5003316971 @default.
• W2085472942 creator A5006839087 @default.
• W2085472942 creator A5027558872 @default.
• W2085472942 creator A5048625267 @default.
• W2085472942 creator A5052779769 @default.
• W2085472942 creator A5085370169 @default.
• W2085472942 creator A5087646613 @default.
• W2085472942 creator A5091863351 @default.
• W2085472942 date "2014-04-27" @default.
• W2085472942 modified "2023-10-18" @default.
• W2085472942 title "Section 13. Short-Course Pretransplant Antiviral Therapy is a Feasible and Effective Strategy to Prevent Hepatitis C Recurrence After Liver Transplantation in Genotype 2 Patients" @default.
• W2085472942 cites W173236885 @default.
• W2085472942 cites W1979815055 @default.
• W2085472942 cites W1981036435 @default.
• W2085472942 cites W1984028098 @default.
• W2085472942 cites W1992520593 @default.
• W2085472942 cites W1998859748 @default.
• W2085472942 cites W2018446644 @default.
• W2085472942 cites W2026614040 @default.
• W2085472942 cites W2029944598 @default.
• W2085472942 cites W2031976676 @default.
• W2085472942 cites W2060057589 @default.
• W2085472942 cites W2061099562 @default.
• W2085472942 cites W2069309210 @default.
• W2085472942 cites W2086838115 @default.
• W2085472942 cites W2121781429 @default.
• W2085472942 cites W2132732585 @default.
• W2085472942 cites W4232907328 @default.
• W2085472942 doi "https://doi.org/10.1097/01.tp.0000446277.36181.e7" @default.
• W2085472942 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24849835" @default.
• W2085472942 hasPublicationYear "2014" @default.
• W2085472942 type Work @default.
• W2085472942 sameAs 2085472942 @default.
• W2085472942 citedByCount "6" @default.
• W2085472942 countsByYear W20854729422015 @default.
• W2085472942 countsByYear W20854729422016 @default.
• W2085472942 crossrefType "journal-article" @default.
• W2085472942 hasAuthorship W2085472942A5003316971 @default.
• W2085472942 hasAuthorship W2085472942A5006839087 @default.
• W2085472942 hasAuthorship W2085472942A5027558872 @default.
• W2085472942 hasAuthorship W2085472942A5048625267 @default.
• W2085472942 hasAuthorship W2085472942A5052779769 @default.
• W2085472942 hasAuthorship W2085472942A5085370169 @default.
• W2085472942 hasAuthorship W2085472942A5087646613 @default.
• W2085472942 hasAuthorship W2085472942A5091863351 @default.
• W2085472942 hasBestOaLocation W20854729421 @default.
• W2085472942 hasConcept C104317684 @default.
• W2085472942 hasConcept C126322002 @default.
• W2085472942 hasConcept C135763542 @default.
• W2085472942 hasConcept C141071460 @default.
• W2085472942 hasConcept C185592680 @default.
• W2085472942 hasConcept C203014093 @default.
• W2085472942 hasConcept C2522874641 @default.
• W2085472942 hasConcept C2776408679 @default.
• W2085472942 hasConcept C2776455275 @default.
• W2085472942 hasConcept C2776461080 @default.
• W2085472942 hasConcept C2779609443 @default.
• W2085472942 hasConcept C2780040827 @default.
• W2085472942 hasConcept C2911091166 @default.
• W2085472942 hasConcept C55493867 @default.
• W2085472942 hasConcept C71924100 @default.
• W2085472942 hasConcept C90924648 @default.
• W2085472942 hasConceptScore W2085472942C104317684 @default.
• W2085472942 hasConceptScore W2085472942C126322002 @default.
• W2085472942 hasConceptScore W2085472942C135763542 @default.
• W2085472942 hasConceptScore W2085472942C141071460 @default.
• W2085472942 hasConceptScore W2085472942C185592680 @default.
• W2085472942 hasConceptScore W2085472942C203014093 @default.
• W2085472942 hasConceptScore W2085472942C2522874641 @default.
• W2085472942 hasConceptScore W2085472942C2776408679 @default.
• W2085472942 hasConceptScore W2085472942C2776455275 @default.
• W2085472942 hasConceptScore W2085472942C2776461080 @default.
• W2085472942 hasConceptScore W2085472942C2779609443 @default.
• W2085472942 hasConceptScore W2085472942C2780040827 @default.
• W2085472942 hasConceptScore W2085472942C2911091166 @default.
• W2085472942 hasConceptScore W2085472942C55493867 @default.
• W2085472942 hasConceptScore W2085472942C71924100 @default.
• W2085472942 hasConceptScore W2085472942C90924648 @default.
• W2085472942 hasIssue "Supplement 8S" @default.
• W2085472942 hasLocation W20854729421 @default.
• W2085472942 hasLocation W20854729422 @default.
• W2085472942 hasLocation W20854729423 @default.
• W2085472942 hasOpenAccess W2085472942 @default.
• W2085472942 hasPrimaryLocation W20854729421 @default.
• W2085472942 hasRelatedWork W1481102184 @default.
• W2085472942 hasRelatedWork W1586448152 @default.
• W2085472942 hasRelatedWork W1598582479 @default.
• W2085472942 hasRelatedWork W2006840037 @default.
• W2085472942 hasRelatedWork W2024493120 @default.
• W2085472942 hasRelatedWork W2047936743 @default.
• W2085472942 hasRelatedWork W2054669275 @default.
• W2085472942 hasRelatedWork W2330453659 @default.
• W2085472942 hasRelatedWork W2352920887 @default.
• W2085472942 hasRelatedWork W4240085218 @default.
• W2085472942 hasVolume "97" @default.
• W2085472942 isParatext "false" @default.

• next